Health Canada is reviewing two new studies that show Yasmin, the country’s top-selling birth control pill, may put women at a higher risk of blood clots, CBC Marketplace has learned.
The studies were published in the British Medical Journal last month and report that women taking birth control pills containing drospirenone have 2.5 to three times the risk of suffering a blood clot than women on the safest pills on the market….
Thousands of women have reported serious health issues, including pulmonary embolisms, after going on those pills. In some cases, deaths have been reported.
Read the entire piece HERE.